Bhattacharjee Pharmaceuticals And Company Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.88 M
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Bhattacharjee Pharmaceuticals And Company
Bhattacharjee Pharmaceuticals And Company Ltd (BPACL) is a leading Public Limited Indian Non-Government Company incorporated in India on 02 August 1989 and has a history of 35 years and six months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.88 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Bhattacharjee, Mousumi Bhattacharjee, and Debabrata Bhattacharjee serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232WB1989PLC047340
- Company No.
047340
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
02 Aug 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Bhattacharjee Pharmaceuticals And Company?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Bhattacharjee  | Director | 04-Aug-2009 | Current |
| Mousumi Bhattacharjee | Director | 05-Sep-1993 | Current |
| Debabrata Bhattacharjee | Director | 02-Aug-1989 | Current |
Financial Performance of Bhattacharjee Pharmaceuticals And Company.
Bhattacharjee Pharmaceuticals And Company Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bhattacharjee Pharmaceuticals And Company?
In 2017, Bhattacharjee Pharmaceuticals And Company had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bhattacharjee Pharmaceuticals And Company?
Unlock and access historical data on people associated with Bhattacharjee Pharmaceuticals And Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhattacharjee Pharmaceuticals And Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhattacharjee Pharmaceuticals And Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
